Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Coenen, Marieke J H ^a   Enevold, Christian ^b   Barrera, Pilar ^a   Schijvenaars, Mascha M V A P ^a   Toonen, Erik J M ^a   Scheffer, Hans ^a   Padyukov, Leonid ^c   Kastbom, Alf ^d   Klareskog, Lars ^c   Barton, Anne ^e   Kievit, Wietske ^a   Rood, Maarten J ^f   Jansen, Tim L ^g   Swinkels, Dorine ^a   van Riel, Piet L C M ^a   Franke, Barbara ^a   Bendtzen, Klaus ^b   Radstake, Timothy R D J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Rigshospitalet   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f GELDERSE VALLEI HOSPITAL   (Netherlands)

^g MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; TLR5 PROTEIN, HUMAN; TLR7 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PROTEIN SYNTHESIS INHIBITION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; UNITED KINGDOM; CASE CONTROL STUDY; COHORT ANALYSIS; DRUG ANTAGONISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; SWEDEN; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78650748817     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014326     Document Type: Article

References (27)

1. Coenen MJ, Gregersen PK (2009) Rheumatoid arthritis: a view of the current genetic landscape. Genes Immun 10: 101-111.
2. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, et al. (2009) Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 41: 1313-1318.
3. Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, et al. (2008) Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum 58: 3684-3692.
4. Roelofs MF, Joosten LA, bdollahi-Roodsaz S, van Lieshout AW, Sprong T, et al. (2005) The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum 52: 2313-2322.
5. van der Heijden I, Wilbrink B, Tchetverikov I, Schrijver IA, Schouls LM, et al. (2000) Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 43: 593-598.
6. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680.
7. Lee EY, Yim JJ, Lee HS, Lee YJ, Lee EB, et al. (2006) Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis. Int J Immunogenet 33: 211-215.
8. Sanchez E, Orozco G, Lopez-Nevot MA, Jimenez-Alonso J, Martin J (2004) Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 63: 54-57.
9. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, et al. (2004) The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 50: 999-1001.
10. Sheedy FJ, Marinou I, O'Neill LA, Wilson AG (2008) The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to, or severity of, rheumatoid arthritis. Ann Rheum Dis 67: 1328-1331.
11. Kang ES, Lee J (2007) Genotypic analysis of Asp299Gly and Thr399Ile polymorphism of Toll-like receptor 4 in systemic autoimmune diseases of Korean population. Rheumatol Int 27: 887-889.
12. Kilding R, Akil M, Till S, Amos R, Winfield J, et al. (2003) A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol 21: 340-342.
13. Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, et al. (2009) No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 11: R5.
14. Etem EO, Elyas H, Ozgocmen S, Yildirim A, Godekmerdan A (2010) The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int; DOI: 10.1007/s00296-010-1472-8.
15. Kuuliala K, Orpana A, Leirisalo-Repo M, Kautiainen H, Hurme M, et al. (2006) Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Ann Rheum Dis 65: 1241-1243.
16. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362-9367.
17. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
18. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 357: 1199-1209.
19. De Rycke L, Vandooren B, Kruithof E, De Keyser F, Veys EM, et al. (2005) Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy. Arthritis Rheum 52: 2146-2158.
20. Welsing PM, van Riel PL (2004) The Nijmegen inception cohort of early rheumatoid arthritis. J Rheumatol Suppl 69: 14-21.
21. Toonen EJ, Coenen MJ, Kievit W, Fransen J, Eijsbouts AM, et al. (2008) The tumour necrosis factor receptor superfamily member 1b 676T.G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis. Ann Rheum Dis 67: 1174-1177.
22. Hoogendoorn EH, Hermus AR, de VF, Ross HA, Verbeek AL, et al. (2006) Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 52: 104-111.
23. Kastbom A, Bratt J, Ernestam S, Lampa J, Padyukov L, et al. (2007) Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alphablocking agents in patients with rheumatoid arthritis. Arthritis Rheum 56: 448-452.
24. Enevold C, Radstake TR, Coenen MJ, Fransen J, Toonen EJ, et al. (2010) Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis. J Rheumatol 37: 905-910.
25. Taylor JD, Briley D, Nguyen Q, Long K, Iannone MA, et al. (2001) Flow cytometric platform for high-throughput single nucleotide polymorphism analysis. Biotechniques 30: 661-669.
26. Ye F, Li MS, Taylor JD, Nguyen Q, Colton HM, et al. (2001) Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 17: 305-316.
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81: 559-575.